|
|
28903 North Avenue Paine
Valencia, CA 91355 USA
phone:(661) 775-5300
fax:661-775-2081
|
|
| Symbol |
MNKD |
| Exchange |
NASDAQ |
| Founded |
1991 |
| Employees |
|
|
|
| www.mannkindcorp.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| MannKind is a biopharmaceutical company focused on therapeutic products for diseases. |
|
| Management |
| Alfred E. Mann, Chairman of the Board and Chief Executive Officer; Hakan S. Edstrom, President and Chief Operating Officer, Directors; Matthew J. Pfeffer, Corporate Vice President and Chief Financial Officer; Juergen A. Martens, Ph.D., Corporate Vice President of Technical Operations and Chief Technical Officer; Diane M. Palumbo, Corporate Vice President of Human Resources |
| |
|
|
|
|
|
|
|
| Keywords |
| therapies, metabolic, oncology, pharmacology, toxicology |
|
|
|
| Description |
|
MannKind is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory, and autoimmune diseases. Our lead product, the Technosphere Insulin System, which is currently in Phase IIb clinical trials for the treatment of diabetes, consists of our dry-powder Technosphere formulation of insulin and our MedTone inhaler through which the powder is inhaled into the deep lung. We believe the performance characteristics, convenience and ease of use of our proprietary Technosphere Insulin System have the potential to change the way diabetes is treated. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
